Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Hologic

(

HOLX

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.4%. By the end of trading, Hologic rose $0.42 (2.1%) to $20.48 on average volume. Throughout the day, 5,381,413 shares of Hologic exchanged hands as compared to its average daily volume of 3,669,600 shares. The stock ranged in a price between $20.20-$20.60 after having opened the day at $20.33 as compared to the previous trading day's close of $20.07. Other companies within the Health Care sector that increased today were:

GW Pharmaceuticals PLC ADR

(

GWPH

), up 68.6%,

Genvec

(

GNVC

), up 35.1%,

Acura Pharmaceuticals

(

ACUR

), up 27.5% and

Skystar Bio-Pharmaceutical Company

(

SKBI

), up 24.9%.

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. Hologic has a market cap of $5.5 billion and is part of the health services industry. Shares are up 0.7% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates Hologic as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk.

On the negative front,

BioScrip

(

BIOS

), down 18.6%,

Mirati Therapeutics

(

MRTX

), down 12.1%,

ImmuCell Corporation

(

ICCC

), down 10.5% and

Amyris

(

AMRS

), down 10.2% , were all laggards within the health care sector with

HCA Holdings

(

HCA

) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null